Dr. Verelst Rudy SRL
Dr. Verelst Rudy reported total assets of €1.88m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026).
By total assets for 2025, Dr. Verelst Rudy ranks among the 1,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. Verelst Rudy shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +32 % Total assets +32 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Verelst Rudy's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
Dr. Verelst Rudy's financial analysis
- Solvency97.6%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Verelst Rudy
Dr. Verelst Rudy's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0825.441.096
- VAT number
- BE0825441096
- Peppol
- Registered · 0208:0825441096 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Apr 2010
- Registered office
- 3110 Rotselaar
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Verelst Rudy (SRL) has been based in Rotselaar since 2010, active in: medical specialists activities. For 2025, it reports a net profit of 389,060 € and equity of €1.83m; its revenue is not published. Its solvency stands at 97.6%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Verelst Rudy
Companies in the same business, of comparable size and area, outside its group.
- Janssens Daniel Jabbeke · balance sheet €1.88m
- Tinvest Waasmunster · balance sheet €1.88m
- Iepamag Binche · balance sheet €1.87m
- Logim Molenbeek-Saint-Jean · balance sheet €1.88m
- Arenberg24 Other information service activities Antwerp · balance sheet €1.88m
- Torus Terra Tessenderlo-Ham · balance sheet €1.88m
- GenM OG Bilzen Jette · balance sheet €1.88m
- Anlisan Zemst · balance sheet €1.87m
Frequently asked questions about Dr. Verelst Rudy
What is the revenue of Dr. Verelst Rudy?
Dr. Verelst Rudy files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Verelst Rudy?
In Belgium, the VAT number is the company number prefixed with BE: BE0825441096 for Dr. Verelst Rudy, if the company is VAT-registered. Its company number (CBE) is 0825.441.096.
Where is the registered office of Dr. Verelst Rudy?
According to the CBE register, the registered office of Dr. Verelst Rudy is in 3110 Rotselaar.
What is the equity of Dr. Verelst Rudy?
At the close of the 2025 financial year, the equity of Dr. Verelst Rudy amounts to 1,832,328 €, a solvency of 97.6% of total assets.
Who manages Dr. Verelst Rudy?
The register lists 1 active mandates at Dr. Verelst Rudy. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. Verelst Rudy within its sector?
By total assets for 2025, Dr. Verelst Rudy ranks among the 1,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. Verelst Rudy
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →